This replication slows down the movement of food through the digestive tract, ensuring better absorption and regulation of sugars
Glutone-C complements a lifestyle focused on maintaining healthy-looking skin, everyday glow, and an even-looking complexion
Refrigerating unopened vials offers no preservation benefit and may create condensation that obscures lot numbers or loosens labels
Ultomiris (ravulizumab-cwvz) Indication(s): Multiple rare, complement-mediated disorders, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), neuromyelitis optica spectrum disorder (NMOSD) Manufacturer(s): Alexion/AstraZeneca 2024 Sales: $3.92 billion Why it sold so well: Ultomiris, developed by Alexion, AstraZeneca Rare Disease, is emerging as a hematology drug to watch in 2025, driven by strong commercial momentum and expanding clinical uptake in 2024